Publications by authors named "Sella A Provan"

Claim this Profile
I
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Sella A Provan

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study.
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Antonela Botea, Nenad Damjanic, Sella Aarrestad Provan

RMD Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial.
Inger Jorid Berg, Eirik K Kristianslund, Anne Therese Tveter, Joseph Sexton, Gunnstein Bakland, Sella Aarrestad Provan

Ann Rheum Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission in gout is possible: 5-year follow-up in the NOR-Gout study.
Till Uhlig, Johan Stjärne, Lars Fridtjof Karoliussen, Joe Sexton, Tron Eskild, Sella Aarrestad Provan

Semin Arthritis Rheum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls: Reply.
Ingrid Egeland Christensen, Siri Lillegraven, Till Uhlig, Sella Aarrestad Provan

Rheumatol Adv Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.
Till Uhlig, Lars F Karoliussen, Joe Sexton, Sella A Provan, Espen A Haavardsholm

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VR-guided exercise and mindfulness program for people with chronic pain: a randomised controlled cross-over pilot trial.
Sella Aarrestad Provan, Giovanna Calogiuri, Linda Røset, Maren Mariussen, Ingeborg Rosøy

BMC Sports Sci Med Rehabil· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, Merete Lund Hetland, Louise Linde, Sella Aarrestad Provan

RMD Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.
Ingrid Egeland Christensen, Siri Lillegraven, Joseph Sexton, Tore K Kvien, Till Uhlig, Sella Aarrestad Provan

Rheumatol Adv Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
Hilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, Kristin H Bjørlykke, Joseph Sexton, Sella A Provan

Lancet Reg Health Eur· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain sensitization in fibromyalgia. Cross-sectional associations between quantitative sensory testing of pain sensitization and fibromyalgia disease burden.
Pernille Steen Pettersen, Trond Haugmark, Inger Jorid Berg, Hilde Berner Hammer, Tuhina Neogi, Sella Aarrestad Provan

Eur J Pain· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can mindfulness have long-term impact on patients with fibromyalgia? A two-year prospective follow-up study of a mindfulness-based intervention.
Heidi A Zangi, Trond Haugmark, Sella Aarrestad Provan

Rheumatol Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries.
Sella Aarrestad Provan, Lotta Ljung, Eirik Klami Kristianslund, Brigitte Michelsen, Till Uhlig

J Rheumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Zohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, Lykke M Ørnbjerg, Mikkel Østergaard, Sella Aarrestad Provan

Rheumatol Adv Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participatory Development of a Virtual Reality Exercise Program for People with Chronic Pain.
Sella A Provan, Sigbjørn Litleskare, Ole Einar Flaten, Henning Pettersen, Linda Røset

Games Health J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depression.
Brigitte Michelsen, Joseph Sexton, Tore K Kvien, Sella Aarestad Provan, Hilde Berner Hammer

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Asia-Sophia Wolf, Kristin H Bjørlykke, Hilde S Ørbo, Sabin Bhandari, Guri Solum, Sella A Provan

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela Di Giuseppe, Sella A Provan

J Rheumatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Sella Aarrestad Provan

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Sella Aarrestad Provan

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Sella A Provan

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid M Egner, Trung The Tran, Sella A Provan

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration.
Celina K Gehringer, Glen P Martin, Kimme L Hyrich, Suzanne M M Verstappen, Joseph Sexton, Sella A Provan

J Clin Epidemiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of rheumatoid arthritis flare based on SDAI and CDAI.
Victoria Konzett, Andreas Kerschbaumer, Josef S Smolen, Eirik Klami Kristianslund, Sella A Provan

Ann Rheum Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial.
Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik K Kristianslund, Sella A Provan

JMIR Res Protoc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis